Primate ␣-chymases are mast cell neutral proteases that are involved in regulating several regulatory peptides including angiotensin II. Because of significant substrate specificity differences among the chymase group of enzymes, animal models that overexpress primate chymases are crucial for delineating the in vivo function of these enzymes. Activation of ␣-prochymase requires processing enzymes and proteoglycans found in mast cell secretory granules. Thus, the development of models overexpressing active primate chymase requires a mast cell-specific promoter. We show that the 571-base pair (bp) 5-upstream sequence of the baboon chymase gene, which encodes an ␣-chymase, coupled to the prokaryotic lacZ gene allows the targeting of ␤-galactosidase to mast cells in transgenic mice. Tissue expression of the transgene is similar to the expression of the endogenous mouse ␣-chymase mouse mast cell protease-5. A mouse mast cell line that endogenously expresses mouse mast cell protease-5 (JKras mast cells) also selectively supports the expression of this transgene. In vitro transcription studies in JKras mast cells shows the critical role of a GATA cis-regulatory motif in baboon chymase promoter, located ϳ430-bp upstream of the transcription start site. These results suggest that the 571-bp domain of the baboon chymase promoter contains most, if not all, of the mast cell-specific region of the promoter. We describe here for the first time a promoter that directs expression of transgenes specifically to mouse mast cells. This promoter should be generally applicable for dominant expression of mast cell regulatory proteins.
Mast cells originate from hematopoietic stem cells, but mature mast cells reside in mucosal and connective tissue (1) . Through the release of proteases, cytokines, and other chemical mediators, mast cells participate in a variety of immunological, inflammatory, and cardiovascular responses. Mast cell proteases include chymases, tryptases, and carboxypeptidase A (2) . Our recent studies and those of other investigators suggest that chymases can activate and inactivate regulatory peptides and thus can produce complex effects on the cardiovascular system. For example, some chymases, e.g. human, baboon, and dog chymases, form angiotensin II efficiently (3, 4) , whereas other chymases, e.g. rat chymase-1, degrade angiotensin II (5, 6) . Angiotensin II is a potent vasoconstrictor peptide (7) and a myocyte growth factor (8) . Recent phylogenetic studies indicate that mammalian chymases occur in two distinct isoenzyme groups, ␣ and ␤ (6). A single chymase gene (chm gene) encoding an ␣-chymase has been identified in all mammals studied, including human, baboon, dog, rat, gerbil, and mouse (6, 9 -12) . In contrast, ␤-chymases are species-specific. Mice, rat, and gerbil contain four, two, and one ␤-chymase-encoding chm genes, respectively (6, 11) . ␤-Chymases have not been demonstrated to be present in humans and baboons. Substrate specificity studies indicate that ␣-and ␤-chymases differ in their specificities and that there are more subtle substrate specificity differences between some ␣-chymases (3) (4) (5) (6) 13) .
Although the overall function of mast cells can be explored in mast cell-deficient mice, the in vivo role of ␣-chymases cannot be delineated because highly specific inhibitors of these proteases are not currently available. Also, subtle differences in substrate specificity between mammalian ␣-chymases make questionable the use of rodent models for the study of primate ␣-chymase function. One approach toward understanding the in vivo role of primate ␣-chymases is to create transgenic models that overexpress functionally active forms of these enzymes. Our recent studies show that the chymase propeptide sequence is important in the correct folding of this protease within the cell (14) and activation of prochymase requires heparin and dipeptidylpeptidase I, which occur abundantly in mast cells (15) . Therefore, to assess the effect of dominant expression, it is necessary to target the zymogen to mast cells to ensure processing and proper tissue localization of chymase. The unavailability of a promoter that selectively targets the mast cell in vivo has hampered investigation of the in vivo role of these mast cell proteases.
We recently cloned the baboon chm gene, including its ϳ2.5-kb 1 5Ј-upstream sequence. The 5Ј-upstream sequence of this gene is highly homologous to the corresponding region of the human chm gene described by Caughey et al. (16) . In this report we show that the 571-bp 5Ј-upstream sequence of the baboon chm gene coupled to the prokaryotic lacZ gene allows the targeting of the ␤-galactosidase reporter to mast cells in transgenic mice. We also show that tissue expression of the lacZ gene directed by the baboon chm 571-bp 5Ј-upstream region is similar to the endogenous pattern of expression of the mouse ␣-chymase mmcp5 and that this promoter is highly * This work was supported by National Institutes of Health Grant HL44201. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. active in JKras mast cells, a mouse mast cell line that endogenously expresses mmcp5. Furthermore, in vitro transcriptional studies in this mouse mast cell line demonstrate the critical role of a GATA cis-regulatory motif in baboon chm promoter-directed expression of the reporter gene. These studies provide a novel tool for the specific expression of genes in mast cells that is likely to be crucial in uncovering the in vivo role of primate chymases as well as other mast cell proteins and provide insight into cis-trans interactions that may be important in baboon chm gene expression in mast cells.
EXPERIMENTAL PROCEDURES
Size-selected Baboon Genomic Library Construction, Gene Cloning, and Primer Extension Analysis-Southern blot analysis indicated the presence of a single 7-kb EcoRI-digested band from baboon genomic DNA that hybridized to a 32 P-labeled human chymase cDNA probe. EcoRI-digested 6 -8-kb fragments of baboon genomic DNA were cloned into a phage gt10 vector system (Stratagene, La Jolla, CA) as per manufacturer's protocol. The 7-kb insert, which strongly hybridized to the human chymase cDNA probe, was subcloned into a pBluescript KS ϩ phagemid (Stratagene). The nucleotide sequence of the overlapping fragments was determined in both directions.
The 5Ј-end of baboon heart-derived chymase mRNA was defined by primer extension analysis (17) . Poly(A) ϩ RNA, prepared from the baboon left cardiac ventricle, was incubated for 1 h at 42°C in a reaction buffer containing Moloney murine virus reverse transcriptase (Boehringer Mannheim) and a 30-bp 32 P-labeled oligonucleotide derived from the 3Ј-end of the first exon of the baboon chm gene. After phenol/ chloroform extraction and ethanol precipitation, the sample was electrophoresed on a 6% polyacrylamide gel, and the size of the prominent radiolabeled DNA fragment extended onto the primer was determined.
Plasmid Construction and Generation of Transgenic Mice-The lacZ gene was released from a pSV-␤-galactosidase plasmid by SalI and BamHI digestion (the SalI site is created by PCR and located just before the ATG translation start site). Two different transgenes were constructed by ligation of 2,426-or 571-bp fragments of the baboon chm gene's 5Ј-upstream region with the lacZ gene. The linearized transgene constructs were microinjected (18) ; ϳ2 pl of the DNA solution (ϳ1000 copies) was microinjected into one pronucleus of each mouse (FVB) F2 embryo. Injections were made by the Transgenic Core Facility of the Cleveland Clinic Foundation. Two-cell stage embryos were transferred to the oviducts of 0.5-day post-coitus pseudopregnant Swiss FBR females. The offspring were screened for transgene integration by Southern blot analysis of tail DNA using a 32 P-labeled 3.34-kb prokaryotic lacZ gene as probe.
Histochemistry-A previously described histochemical staining procedure was used to assess ␤-galactosidase activity (18) . Three-week-old transgenic mice as well as their nontransgenic littermates were sacrificed. Tissue samples from each mouse were fixed for 40 -60 min in 2% formaldehyde, 0.2% gluteradehyde, 0.02% Nonidet P-40, and 0.01% sodium deoxycholate in phosphate-buffered saline, embedded in the embedding medium OCT and frozen on dry ice. Serial 6-m tissue sections were cut with a cryostat, loaded on charge-coated slides (Fisher), and refixed in the same solution for 10 min. After three washes in phosphate-buffered saline, sections were submerged in 0.1 M phosphate buffer, pH 7.3, containing 1 mg/ml 4-chloro-5-bromo-3-indolyl-␤-D-galactoside (Boehringer Mannheim), 2 mM MgCl 2 , 10 mM K 3 Fe(CN) 6 , and 10 mM K 4 Fe(CN) 6 . Incubation was carried out for 3-4 h at 37°C. After 4-chloro-5-bromo-3-indolyl-␤-D-galactoside staining, sections were dehydrated and mounted in Permount (Fisher). Adjacent slides were stained with hematoxylin and eosin or with 1% toluidine blue (T-blue).
Northern Blot Analysis-Total RNA was isolated from 1 ϫ 10 8 cells using an RNAzol kit (TEL-TEST, Friendswood, TX). 20-g RNA samples were size-fractionated on a 1% formaldehyde-agarose gel and transferred to a nitrocellulose filter (19) . After UV cross-linking, the blot was hybridized with 32 P-labeled human chymase cDNA at high stringency.
Cell Lines and Tissue Culture-Mouse mastocytoma P815 cells, mouse erythroid leukemia (MEL) cells, and NIH3T3 (3T3) fibroblasts were obtained from the American Type Culture Collection. JKras mast cells (20) were obtained from Dr. James N. Ihle (St. Jude Children's Research Hospital, Memphis, TN). P815 mast cells and MEL cells were maintained in RPMI 1640 medium containing 10% fetal bovine serum. JKras mast cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum and murine interleukin-3 (20 units/ml). 3T3 fibroblasts were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. Cells were kept at 37°C in an atmosphere of 5% CO 2 and split (ϳ1:4) every 5 days.
Construction of Recombinant Plasmids-Baboon chm promoter-CAT chimeras were made by fusing varying lengths of the baboon chm gene's 5Ј-upstream sequence to the coding sequences for CAT. These baboon chm promoters of varying lengths were generated by PCR amplification. For each construct two primers were used; each contained either a terminal PstI site or a SalI site to facilitate cloning into the PstI and SalI sites immediately upstream of the CAT reporter gene in the plasmid pSV40-CAT enhancer (Promega, Madison, WI). The number following the ⌬ in Fig. 1 indicates the end of the 5Ј-upstream sequence with respect to the transcription-initiation site (designated ϩ1) was determined by primer extension analysis. In addition to the specified amounts of the 5Ј-upstream sequence, these constructs contained the transcription-initiation site and 30 bp of the 5Ј-upstream region between the transcription-initiation site and the putative translation start site of the baboon chm gene.
Transient Cell Transfection and CAT Activity Assays-Transient transfection of 3T3 fibroblasts was performed using the calcium/phosphate co-precipitation method (19) . JKras mast cells and P815 mast cells were transiently transfected by the DEAE-dextran method (19) . As an internal control for these transfections, the pSV-lacZ plasmid was co-transfected with the test plasmid (1:5). The cells were harvested and ruptured by three freeze-thaw cycles. One-half of the extract was heated for 10 min at 65°C to destroy endogenous deacetylating activity. After removal of the cellular debris, the heat-treated extract was assayed for CAT activity. The remaining extract was assayed for ␤-galactosidase activity. Based on ␤-galactosidase activity, CAT activity in each sample was adjusted for between plate and between experiment variability in transfection efficiency. Transient transfection of COS-1 cells was performed using the DEAE-dextran method (19) . The pSVlacZ plasmid was co-transfected with the test plasmid (1:5) as an internal control. Human GATA-2 cDNA plasmid, a gift from Dr. S. H. Orkin (Harvard Medical School, Boston), was co-transfected with the ⌬571-bchm-CAT construct to determine transcriptional activation of this promoter construct by human GATA-2. CAT activity in each sample was adjusted for between plate and between experiment variability in transfection efficiency.
Cell-free Transcription Assays-JKras mast cell nuclear extracts were prepared as described previously (21) . Nuclear extracts were dialyzed overnight at 4°C against 20 mM HEPES buffer, pH 7.9, containing 100 mM KCl, 1 mM EDTA, 1 mM EGTA, 0.5 mM dithiothreitol, 1 g/ml aprotinin, 0.5 mM phenylmethylsulfonyl fluoride, and 25% glycerol, and stored at Ϫ70°C. In vitro transcription reactions were performed with 2 nM supercoiled template DNA and 10 -15 l of nuclear extract (10 -15 mg/ml) in a 50-l reaction mixture containing 12 mM HEPES buffer, pH 7.9, containing 50 mM KCl, 25 mM (NH 4 ) 2 SO 4 , 7.5 mM MgCl 2 , 0.1 mM EDTA, 0.3 mM dithiothreitol, 2 units of RNasin, 12% glycerol, 600 M ATP, 600 M UTP, 600 M GTP, 25 M CTP, and 10 Ci of [␣-32 P]CTP (Amersham Corp.). Transcription reactions were allowed to proceed for 60 min at 30°C and terminated by the addition of 0.2% SDS, 10 mM EDTA, and 100 g of tRNA carrier/ml. RNA in the transcription mixture was extracted with 200 l of phenol/chloroform/ isoamyl alcohol (25:24:1), ethanol precipitated, and dissolved in diethyl pyrocarbonate-treated Tris/HCl buffer, pH 8.0, containing 1 mM EDTA. The RNA samples were separated on a 1% formaldehyde-agarose gel in 1 ϫ MOPS buffer, transferred to a nitrocellulose filter, and subjected to autoradiography for 16 h.
Electrophoretic Mobility Shift Assays-Electrophoretic mobility shift assays were performed as described (22) . Binding reactions were performed with 20 g of JKras mast cell nuclear extract and ϳ0.5 ng of 32 P-labeled oligonucleotide corresponding to a fragment (Ϫ417 to Ϫ441 bp) of the baboon chm promoter (100,000 cpm) in 20 mM HEPES buffer, pH 7.9, containing 50 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 5% glycerol, 100 mg/ml bovine serum albumin, and 1 g/ml poly d(I-C). To study the effect of competitor oligonucleotides on the binding of the 32 P-labeled oligonucleotide to JKras mast cell nuclear trans-acting factors, a 10-, 30-, or 60-fold excess of competitor oligonucleotide was added to the reaction mixture 10 min before the addition of the radiolabeled probe.
32 P-Labeled DNA-protein complexes were resolved from unbound radiolabeled DNA on 6% polyacrylamide gels run in 22.5 mM Tris borate buffer, pH 8.3. The gels were dried under vacuum and autoradiographed for ϳ16 h.
Reverse Transcriptase (RT)-PCR-Single-stranded cDNAs were prepared from total RNA from JKras mast cells, MEL cells, P815 cells, 3T3 fibroblasts, and mouse spleen and from tissues from the transgenic mice and their nontransgenic littermates using oligo(dT) primers and Moloney murine virus reverse transcriptase. The resulting single-stranded cDNAs were amplified using a 0.5 M concentration of each primer. For mmcp5, 5Ј-TTCTGAGAACTACCTGTCGGCC-3Ј was used as the sense strand, and 5Ј-GAATTGTGTCGAAAACTGGTGAAGTG-3Ј was used as the antisense strand. For mouse GATA-1, 5Ј-CAACAGTAT-GGAGGGAATTCCTGGGGGCT-3Ј was used as the sense strand, and 5Ј-GGCCGGTTCTGACCATTCATTTTGTGATA-3Ј was used as the antisense strand. For mouse GATA-2, 5Ј-GACGGAGAGCATGAAGAT-GG-3Ј was used as the sense strand, and 5Ј-AGGCATTGCACAGGTAG-TGG-3Ј was used as the antisense strand; these primers were based on the sequence of human GATA-2. For mouse GATA-3, 5Ј-CCTTGGAAC-CTCAGCCCTTTTTCCAAGACCTCCA-3Ј was used as the sense strand, and 5Ј-GGCCGGTTCTGACCATTCATTTTGTGATA-3Ј was used as the antisense strand. For lacZ, 5Ј-CCAGCGTTTCAACGCGCTGTATGG-CG-3Ј was used as the sense strand, and 5Ј-AGACGTCACGGAAAAT-GCCGCTCATC-3Ј was used as the antisense strand. For GAPDH, 5Ј-CAAAGTTGTCATGGATGACCTTGGC-3Ј was used as the sense strand, and 5Ј-GTCTTCACCACCATGGAGAAGGCTG-3Ј was used as the antisense strand.
Statistical Analyses-Autoradiographic data were analyzed using a Molecular Dynamics PhosphorImager. RT-PCR agarose gel bands were quantitated using a densitometric image analyzer (densitometer) driven by a Macintosh computer. Quantitative data are presented as the means Ϯ S.E., and differences between means were evaluated using a Student's t test, with p Ͻ 0.05 considered statistically significant.
RESULTS

Structure of the Baboon chm Gene-
The nucleotide sequence and organization of the baboon chm gene is shown in Fig. 1 . Based on a comparison with the baboon chymase cDNA structure, this gene has five coding blocks. The first coding block is 58 bp in length; it encodes, in an open reading frame, the first 19 amino acids (Ϫ21 to Ϫ3) of the preproenzyme. The second, third, fourth, and fifth coding blocks of the baboon chm gene encode amino acids Ϫ2 to 49, 50 to 94, 95 to 179, and 180 to 226. As assessed by primer extension analysis, the primary transcription-initiation site of the baboon chm gene is 30 bp upstream of the translation-initiation site (data not shown). The translation-initiation ATG codon of the baboon chm gene was predicted based on the structure of the baboon chymase cDNA. The 5Ј-upstream region of the baboon chm gene contains a CAAT and a TATA box, Ϫ108 to Ϫ105 bp and Ϫ29 to Ϫ25 bp upstream, respectively, of the transcription-initiation site. A consensus polyadenylation motif, AATAAA, which is followed by a cleavage site motif, consisting of a CA sequence located 15 bp downstream along with a GT cluster, is found in the 3Ј-untranslated region. The structure of the baboon chm gene's 5Ј-upstream region (Ϫ2,426 to Ϫ1 bp) is ϳ92% identical to that of the human chm gene. Baboon chymase is 97% identical to human chymase (9) and 76% identical to its mouse homolog mmcp5 (12) .
Cell-and Tissue-specific Expression of Baboon chm-lacZ Transgenes-To identify the baboon chm promoter, two constructions were made. These constructs consist of 571-and 2,426-bp 5Ј-upstream sequences of the baboon chm gene linked to the prokaryotic lacZ gene, i.e. ⌬571-bchm-lacZ and ⌬2,426-bchm-lacZ, respectively. ⌬571-bchm-lacZ and ⌬2,426-bchmlacZ constructions were used to generate transgenic founders. Germline transmission occurred with ⌬571-bchm-lacZ (two female and one male founder) and ⌬2,426-bchm-lacZ (1 male founder) constructs. A ⌬571-bchm-lacZ male founder and a ⌬2,426-bchm-lacZ male founder were used to generate F 1 transgenic heterozygous mice. Subsequent tissue and cell expression of the lacZ gene was determined in F 1 heterozygous transgenic mice.
Tissue expression of ␤-galactosidase mRNA in transgenic heterozygous mice and mmcp5 expression in nontransgenic littermates was quantified using RT-PCR. Ratios of mmcp5/ GAPDH in tissues from nontransgenic mice and lacZ/GAPDH mRNA in tissues from ⌬571-bchm-lacZ and ⌬2,426-bchm-lacZ transgenic mice are summarized in Fig. 2 . The relative distribution of GAPDH-normalized lacZ expression in the stomach, intestine, spleen, heart, lung, and brain tissues was similar between the ⌬571-bchm-lacZ and ⌬2,426-bchm-lacZ constructs and also similar to that of mmcp5. To identify the cell types in transgenic mice that express the lacZ gene, we examined Tblue-staining cells (T-blue produces a deep purple stain in mast cells) and ␤-galactosidase-containing cells in serial sections of the stomach from the ⌬571-bchm-lacZ and ⌬2,426-bchm-lacZ transgenic mice. Fig. 3 indicates the selective expression of ␤-galactosidase in T-blue staining cells in the submucosa of the stomach from a ⌬571-bchm-lacZ transgenic mouse. Similar results were observed in the gastric submocosa and small intestine of other ⌬571-bchm-lacZ (n ϭ 2) and ⌬2,426-bchm-lacZ (n ϭ 2) transgenic mice (data not shown). Fig. 4 shows representative cells in the ⌬571-bchm-lacZ transgenic left cardiac ventricle staining for T-blue or ␤-galactosidase. To determine if ⌬571-bchm promoter-driven lacZ expression occurs in circulating mast cell progenitors, leukocytes from ⌬571-bchm-lacZ transgenic mice were examined for ␤-galactosidase activity. ␤-Galactosidase activity was not observed in several leukocyte samples (data not shown).
Baboon chm Gene 5Ј-Flanking Region Directs CAT Expression in JKras Mast Cells, but Not P815 Mast Cells-We examined several murine mast cell lines to see which ones endogenously express the mouse ␣-chymase mmcp5. Using a human chymase (an ␣-chymase-like mmcp5 (6)) cDNA probe, Northern blot analysis indicated chymase-like mRNA in mouse JKras mast cells but not in mouse mastocytoma P815 cells or mouse erythroid leukemia MEL cells (Fig. 5A) . Using mouse chymase subtype selective PCR primers, Fig. 5B shows that JKras mast cells contain mmcp5 mRNA. Using mouse ␤-chymase subtypeselective PCR primers showed the absence of ␤-chymase mRNA in JKras mast cells (data not shown). JKras mast cells are interleukin-3-dependent Harvey sarcoma virus-infected immune mast cells from the mouse spleen (20) . Fig. 5 shows that mmcp5 is endogenously expressed in JKras mast cells but not P815 mast cells. To examine whether this discrimination in the expression of an ␣-chymase-encoding chm gene in these two mast cell lines is mimicked by the transcriptional activity of the ⌬571 baboon chm promoter-CAT construction, ⌬571-directed expression of the CAT gene was determined in JKras mast cells and P815 mast cells and compared with its transcriptional activity in 3T3 fibroblasts. Table I directed by ⌬571 in JKras mast cells was 25-fold higher than in P815 mast cells and 51-fold higher than in mouse 3T3 fibroblasts.
A
GATA-binding cis-Regulatory Element in the Baboon chm Promoter Is Essential for Transcription in JKras Mast
Cells-We studied the in vitro regulation of the baboon chm promoter in JKras mast cells. To map the location of cis-acting elements within the baboon chm promoter, transcription studies were carried out in JKras mast cell nuclear extracts with deletion mutants of the 571-bp baboon chm promoter-CAT construct (⌬571-bchm-CAT). The results are summarized in Fig. 6 . The transcriptional activity of the ⌬453-bchm-CAT construct was 11-fold greater than of the ⌬426-bchm-CAT construct but similar to that of ⌬571-and ⌬506-bchm-CAT constructs, indicating the presence of a positive regulatory element between Ϫ426 and Ϫ453 bp of the baboon chm gene's 5Ј-upstream region. Motif analysis indicates that this region contains a GATA-binding element, situated at Ϫ432/Ϫ427 bp upstream of the transcription-initiation site. To determine if the putative Ϫ432/Ϫ427 GATA-binding site is a necessary for transcription, we examined transcriptional activities of the ⌬435-bchm-CAT construct and its mutant [A Ϫ430 3 C]-⌬435-bchm-CAT containing a defective GATA-binding site (Fig. 7) . Transcriptional activity of [A
Ϫ430
3 C]-⌬435-bchm-CAT in JKras mast cell nuclear extracts was ϳ12-fold lower than that of ⌬435-bchm-CAT, indicating the importance of this single GATA cis-regulatory site in the transcriptional activation of the baboon chm gene.
Previous studies have indicated synergistic interactions between GATA and other transcription factors in gene regulation (23, 24) . To identify putative cis-acting elements in the ⌬571-bchm-CAT construct that could synergize with the GATA cisregulatory element, transcriptional activity of additional ⌬571-bchm-CAT mutants was examined. Deletion of the 139-bp sequence in the ⌬571-bchm-CAT construct 5Ј-upstream of the GATA site (i.e. ⌬432-bchm-CAT) did not reduce the transcriptional activity of the mutant promoter construct in JKras mast cell nuclear extract (construct 2, Fig. 8 ). However, replacement of the 41-bp sequence immediately 3Ј to the GATA site in the ⌬432-bchm-CAT construct with an indifferent sequence produced a ϳ50% decrease (p Ͻ 0.05) in transcription (construct 3, Fig. 8 ). This indifferent sequence, shown in Fig. 8 , was 41% homologous to the wild type. Deletion of a 333-bp sequence, Ϫ386 to Ϫ53 bp upstream of the transcription-initiation site, in the ⌬432-bchm-CAT construct did not affect transcriptional activity (construct 4, Fig. 8 ).
GATA-2 Is Present in JKras Mast Cells and Supports Transcription of the Baboon chm
Promoter-Electrophoretic mobility shift analysis using an end-labeled DNA fragment comprising the sequence Ϫ441 to Ϫ417 bp of the baboon chm promoter containing a GATA-binding element indicated the presence of a trans-acting factor in JKras mast cell nuclear extracts (Fig. 9) . To characterize the specificity of this binding, competition assays were performed using mutated forms of the Ϫ441/Ϫ417 baboon chm gene DNA fragment. Mutation of the GATA sequence to GcTA or cATA produced a loss of binding to the JKras mast cell trans-acting factor (Fig. 9) . The sequence specificity illustrated by these experiments is similar to that previously shown for GATA-1, GATA-2, and GATA-3 binding proteins (25) .
RT-PCR analysis with specific primers for GATA-1, GATA-2, and GATA-3 was used to examine expression of these transcription factors in JKras mast cells. Fig. 10 shows that GATA-2 but not GATA-1 or GATA-3 mRNA is present in JKras mast cells and P815 mast cells. The presence of GATA-1 but not GATA-2 or GATA-3 mRNA in MEL cells and GATA-2 mRNA in P815 cells has previously been shown. These observations of GATA-binding protein subtypes in MEL and P815 cells indicates the specificity of these PCR primers (Fig. 10) . Because GATA-3 mRNA could not be identified in these cells as a positive control, RT-PCR analysis was also performed with total RNA from mouse spleen, which is known to contain lymphoid cells expressing GATA-3. The absence of GATA-1, GATA-2, and GATA-3 mRNA in 3T3 fibroblasts also indicates the specificity of the PCR primers.
To determine if ectopically expressed GATA-2 can support ⌬571-bchm-CAT expression in a heterologous cell, we determined transcriptional activity of the ⌬571-bchm-CAT construct in COS-1 cells transfected with a human GATA-2 cDNA construct (26) . Fig. 11 shows an ϳ5-fold increase in transcription of the ⌬571-bchm-CAT construct in COS-1 cells transfected with human GATA-2 cDNA compared with mock transfected COS-1 cells. DISCUSSION Chymase occurs in numerous human (10) and baboon (27) tissues including the alimentary tract, heart, lungs, blood vessels, and reproductive tissues is implicated in diverse functions and represents a differentiation-specific marker that identifies a population of mature tissue resident mast cells (28) . Using a transgenic approach, we show that the 571-bp 5Ј-upstream region of the baboon chm gene is a promoter that allows re- stricted mast cell expression of a reporter gene. These findings, as well as our identification of a critical cis-and trans-acting positive regulatory element within this promoter, shed light on how chm genes are transcriptionally regulated.
Introduction in mice of constructs containing 0.571-or 2.426-kb fragments of the 5Ј-upstream region of the baboon chm gene coupled to the prokaryotic lacZ gene, i.e. ⌬571-bchmlacZ or ⌬2,426-bchm-lacZ, respectively, allows the restricted expression of ␤-galactosidase in T-blue staining mast cells resident in the gastric submocosa of transgenic mice. Cells containing ␤-galactosidase with mast cell-like granules were also detected in the heart and intestine of mice containing the ⌬571-bchm-lacZ transgene; however, because the ␤-galactosidase-containing cells from the heart did not cluster like mast cells of the gastric submucosa, it was not possible to confirm from T-blue staining of adjacent sections whether these cells were mast cells. Circulating progenitor mast cells must normally be resident in tissue before ultrastructural characteristics and protease expression patterns associated with fully differentiated mast cells are observed (1). We did not observe any cells with ␤-galactosidase activity in circulating leukocyte samples from mice harboring the ⌬571-bchm-lacZ transgene. The relative lack of expression of the lacZ gene in brain tissue is also relevant to tissue-specific expression of the chm gene. Blood cells cannot readily penetrate the blood-brain barrier, and thus progenitor mast cells cannot get into brain tissue. These observations illustrate the high fidelity of the 571-bp 5Ј-upstream region of the baboon chm gene in conferring development-specific in vivo expression of the lacZ gene in mast cells. Previously, our in situ hybridization and electron microscope immunohistochemical studies showed the presence of human chymase and its mRNA in some vascular endothelial cells (10) . In all tissues studied from mice expressing the ⌬571-bchm-lacZ or ⌬2,426-bchm-lacZ transgenes, ␤-galactosidase activity was not detected in endothelial cells. This finding suggests that either mouse endothelial cells do not contain trans-activating factors necessary for chymase expression or cis-regulatory sequences other than those present in the ϳ2.5-kb 5Ј-upstream fragment of the baboon chm gene are required for chymase expression in endothelial cells.
Distribution of ␤-galactosidase mRNA in tissues from mice containing the ⌬571-bchm-lacZ or ⌬2,426-bchm-lacZ transgenes was similar to the distribution of mmcp5 mRNA (mmcp5 is the mouse ␣-chymase). Given that the same observations were made in two independently generated groups of transgenic mice, we believe that transcriptional specificity in transgene expression is likely to be due to baboon chm regulatory sequences rather than to integration of the constructs near a strong endogenous mast cell regulatory domain. These studies and the observation that ⌬571-bchm-driven CAT expression is high in a mouse mast cell line that endogenously expresses the 
TABLE I Relative activity of a baboon chm gene 5Ј-flanking region in different mouse cells
Relative CAT expression directed by pSV40 and the 571-bp 5Ј-flanking region of the baboon chm gene (⌬571). The pSV40 contains the SV40 promoter and its enhancer. For each cell type (mean Ϯ S.E.; n ϭ 3), CAT activity is expressed relative to that of the pSV40-CAT control construction, which is defined as 1. The cell specificity ratio represents the relative CAT activity obtained in the JKras mast cell (JKras) relative to that obtained in P815 mast cells (P815) or 3T3 fibroblasts (3T3 cells). (29) . Because heparin sulfate but not chondroitin sulfate is an important cofactor in ␣-prochymase activation (15), ⌬571-bchm-driven zymogen expression in vivo is likely to lead to ␣-prochymase activation in connective tissue mast cells but not in mucosal mast cells. Transcriptional regulation of a gene is achieved through interactions of cis-regulatory regions uniquely present in a gene and cell-specific trans-activating factors with components of the basal transcriptional complex assembled at the initiation site. We used the ⌬571-bchm-CAT promoter construct to identify cis-regulatory regions of the baboon chm promoter critical for transcriptional activation in JKras mast cells. Deletional and site-specific mutational analyses revealed a strong cis- FIG. 8 . Transient expression of a wild type ⌬571-bchm-CAT construct (construct 1), a ⌬432-bchm-CAT construct (construct 2), a ⌬432-bchm-CAT mutant construct in which the 41-bp region 3 to the GATA site was replaced with an indifferent sequence (construct 3), and a ⌬432-bchm-CAT mutant construct with a 333-bp deletion between ؊386 and ؊53 bp (construct 4). The data represent CAT mRNA accumulation, relative to that of SV40, during transient expressions of the constructs in a cell-free transcription system using JKras mast cell nuclear extract (n ϭ 3). Relative transcription activity for constructs 2 and 4 was not different from that of wild type baboon chm promoter construct, but activity of construct 3 was 47% of that of the wild type construct (p Ͻ 0.05). The indifferent 41-bp sequence used in construct 3, i.e. 5Ј-ACAACAATTTTGTAGTAT-TAGTATGTCTCATTCAATATTTG-3Ј, was 41% homologous to the wild type. The sequence of the DNA fragments that were deleted is shown in Fig. 1.   FIG. 9 . DNA binding activity of JKras nuclear proteins. A 25-bp DNA fragment spanning the AGATAA-site from the bchm promoter comprising the region Ϫ444 to Ϫ417 bp was used as the probe in electrophoretic mobility shift assays. The arrow indicates the position of the specifically labeled band. Competitor DNA fragments include the unlabeled 25-bp fragment used as the probe (GATA), the G Ϫ431 to C mutant of the GATA 25-bp fragment (cATA), and the A Ϫ432 to C mutant of the GATA 25-bp fragment (GcTA). Lane 1 is competitor-free. Lanes 2, 5, and 8, lanes 3, 6 , and 9, and lanes 4, 7, and 10 contain a 10-, 30-, and 60-fold excess of competitor DNA, respectively. acting positive regulatory GATA element between Ϫ453 to Ϫ426 bp upstream of the transcription-initiation site. A GATAbinding site is also present ϳ430 and ϳ100 bp upstream of the transcription-initiation site of the human chm (16, 30) and mmcp5 (12) genes, respectively, and therefore, GATA-binding proteins could be involved in transcriptional activation of these ␣-chymase encoding chm genes in mast cells.
We found GATA-2 but not GATA-1 or GATA-3 DNA-binding proteins in JKras mast cells. The further observation that CAT activity in COS-1 cells increases by ϳ5-fold after transfection with human GATA-2 cDNA shows the importance of this transcription factor in trans-activation of the baboon chm promoter. GATA-1, GATA-2, and GATA-3 transcription factors have markedly differing patterns of cellular expression, but they recognize the same cis-regulatory motif (A/T)GATA(A/G) (31) . In cell-dependent expression of genes requiring a GATA cistrans-interaction, a high level of transcriptional activation can be achieved through synergistic interactions with other transcription factors. For example, GATA-1 and Krü ppel family factors cooperate from a distance in directing expression of the globin gene in erythroid cells (23) . A similar cooperative interaction has been described between GATA-2 and AP1 in transactivation of the endothelin-1 gene (24) . In these examples, synergistic interactions between GATA and Sp1, AP1, or EKLF produce a substantial effect, i.e. a Ͼ10-fold increase in transcription over a simple additive effect. Using motif analysis, we were unable to locate cis-regulatory motifs for AP1, Sp1, or EKLF in the 571-bp baboon chm promoter. Furthermore, deletion or replacement of DNA sequences 5Ј or 3Ј to the GATA cis-regulatory element produced small decreases (Ͻ50%) in transcriptional activation of the ⌬571-bchm-CAT construct in JKras mast cell nuclear extracts. These data indicate an absence of strong synergistic interactions between GATA-2 and other trans-acting factors in the transcriptional activation of the baboon chm promoter in JKras mast cells.
In summary, we show that the 571-bp 5Ј-upstream sequence of the baboon chm gene can be used to selectively target mouse mast cells in vivo and in vitro and thus provides an important tool in the generation of transgenic mice where proteins need to be targeted to mast cells. We also show that a GATA cis-transinteraction is both necessary and sufficient for transcriptional activation of the baboon chm promoter in vitro in JKras mast cells. However, given that GATA-2 is found in differentiated mast cells but also has an important role early in hematopoietic cell development (31) (32) (33) , it is clear that engaging the GATA cis-regulatory element must be one of multiple cis-trans-interactions necessary for transcriptional specificity. The finding that the P815 mast cell contains abundant GATA-2 but does not support a high level expression of CAT with the ⌬571-bchm-CAT promoter construct suggests that suppression of dominant negative interactions as well as enhanced GATA-2 expression could coordinate chm gene expression as progenitor mast cells differentiate into mature tissue resident mast cells.
The availability of a mast cell-specific promoter now makes it possible to study how chm gene expression is suppressed in primate mast cell progenitors as well as in other GATA transcription factor-expressing hematopoietic cells.
